Plain-English translation of NCT06977035 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a medication called baricitinib affects the nerves in people with rheumatoid arthritis. Researchers will use special tests to measure how well the nerves in your legs and arms are working, and compare results between people taking baricitinib and people taking other rheumatoid arthritis medications. The goal is to understand if this treatment is safe for your nervous system.
Rheumatoid arthritis is treated with medications that reduce joint inflammation, but doctors want to make sure this medication doesn't cause problems with the nerves in your hands and feet. This study will help answer that important safety question.
You likely qualify if…
You likely don't qualify if…
You would come for a nerve conduction study, which is a painless test where small electrodes are placed on your skin to measure how well your nerves are working. The test takes about 30–60 minutes and is done in a clinic. You would be grouped with either people taking baricitinib or people taking other rheumatoid arthritis medications, so researchers can compare how each treatment affects nerve function.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Egypt
Sponsor
Sohag University
Enrollment target
~60 participants
Started
May 2025
Primary completion
November 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sara K Mohamed, Resident
Sohag University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.